financetom
Business
financetom
/
Business
/
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
Nov 20, 2024 7:41 PM

05:02 PM EST, 11/20/2024 (MT Newswires) -- (Updates the stock change in the last paragraph.)

Nvidia ( NVDA ) reported fiscal Q3 non-GAAP earnings late Wednesday of $0.81 per diluted share, up from $0.40 a year earlier.

Analysts polled by FactSet expected $0.75 excluding some items.

Revenue in the three months ended Oct. 27 rose to $35.08 billion from $18.12 billion a year earlier.

Analysts surveyed by FactSet expected $33.17 billion.

The company expects fiscal Q4 revenue of $37.5 billion, plus or minus 2%. Analysts expect $37.09 billion.

Nvidia ( NVDA ) shares fell 0.7% in after-hours activity, paring earlier losses.

Price: 144.81, Change: -1.08, Percent Change: -0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
HeartBeam's Heart Monitoring Device Receives US FDA Clearance
HeartBeam's Heart Monitoring Device Receives US FDA Clearance
Dec 16, 2024
09:07 AM EST, 12/16/2024 (MT Newswires) -- HeartBeam ( BEAT ) said Monday its HeartBeam ( BEAT ) device has received 510(k) clearance from the US Food and Drug Administration for comprehensive arrhythmia assessment. The device tracks heart signals from three directions to provide heart health information, the company said. Shares of HeartBeam ( BEAT ) were up more than...
Honeywell Considers Separation of Aerospace Business as Part of Portfolio Optimization Efforts
Honeywell Considers Separation of Aerospace Business as Part of Portfolio Optimization Efforts
Dec 16, 2024
09:08 AM EST, 12/16/2024 (MT Newswires) -- Honeywell International ( HON ) on Monday said it is evaluating a potential separation of its aerospace business as part of the industrial conglomerate's efforts to optimize its portfolio. The company said its board of directors continues to explore strategic alternatives to unlock shareholder value and has made significant progress so far. Honeywell...
Sector Update: Consumer Stocks Advance Pre-Bell Monday
Sector Update: Consumer Stocks Advance Pre-Bell Monday
Dec 16, 2024
09:06 AM EST, 12/16/2024 (MT Newswires) -- Consumer shares were advancing pre-bell Monday with the Consumer Staples Select Sector SPDR Fund ( XLP ) up 0.2% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) 0.4% higher recently. Alibaba Group Holding ( BABA ) is nearing an agreement to sell its department store business Intime to Youngor Fashion...
Viridian Therapeutics Meets Endpoints in Late-Stage Veligrotug Trial for Thyroid Eye Disease
Viridian Therapeutics Meets Endpoints in Late-Stage Veligrotug Trial for Thyroid Eye Disease
Dec 16, 2024
09:10 AM EST, 12/16/2024 (MT Newswires) -- Viridian Therapeutics ( VRDN ) said Monday that a late-stage trial of candidate drug veligrotug met all of its primary and secondary endpoints for symptoms of chronic thyroid eye disease. Viridian said about 56% of the trial's veligrotug-treated patients experienced a reduction in proptosis or the abnormal bulging of eyes, with a 2.34...
Copyright 2023-2026 - www.financetom.com All Rights Reserved